Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
Compellis Pharmaceuticals, Inc.
141 PowderHouse Blvd. Suite 1
Download information as a
Enter your Name:
Enter your Message:
E-mail a copy of this message to your own address.
Compellis Pharmaceuticals Presents Results of Pilot Clinical Study at Obesity Society Annual Meeting
Pennington Biomedical Research Institute and Compellis Pharmaceuticals Complete Phase I Study of Novel and Patented Obesity Therapy
Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent from the U.S. Patent Office for Novel Obesity Therapy
Pennington Biomedical Research Institute Receives FDA Approval to Begin Phase I Studies of Compellis Pharmaceuticals’ Novel and Patented Obesity Therapy
Compellis Pharmaceuticals Awarded Patent for its Therapeutic Platform for Treating Obesity
Copyright © 2016 Compellis Pharmaceuticals, Inc.. All Rights Reserved. Website by